Status
A multinational clinical project (OligoG-pivotal-CF) to test the orphan drug OligoG CF-5/20 in a pivotal phase 2b clinical trial for the treatment of cystic fibrosis.
Updates
The project status will be updated periodically to reflect the progress of the clinical study. Patient enrolment is due to start H1 – 2019.
The clinical trial will include 120 CF patients from 45 European sites in coordination with the European Clinical Trial Network. In addition the inclusion of at least 5 Australian sites are currently being considered.
EUROPEAN CLINICAL TRIAL NETWORK
The clinical trial will include 120 CF patients from 45 European sites in coordination with the European Clinical Trial Network.
6
Partners
45
European sites
Funding
This project has received funding from the European Union’s Horizon 2020 research and innovation programme part “Health, demographic change and well-being” (call H2020-SC1-2016-2017) under grant agreement No 755234.